retatrutide weight loss clinical data Eli Lilly's shows promising results in phase 3 trial VisualAbstract: Retatrutide reduces body weight

GLP-1 agonists suppress appetite by: Acting on the hypothalamus, the brain region that regulates hunger

This system serves to inhibit blood clot formation and enhance fibrinolysis

Enhancement in executive function: Awareness Cognition Appropriateness Eye contact Responsiveness Normalized behaviours and interaction Promotion of speech and language: Spontaneous language More complex sentences Increased vocabulary Improvements in socialization, understanding and expressing emotion: Initiation and interactive play Understanding and feeling emotions Affection and tolerance to touch Undesired effects to B12 therapy are a good sign of treatment success

PubMed Turner AN, Carr Reese P, Fields KS, Anderson J, Ervin M, Davis JA, Fichorova RN, Roberts MW, Klebanoff MA, Jackson RD